¿¢¼ÒÁ» ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç° ¹× ¼­ºñ½ºº°, ¿öÅ©Ç÷ο캰, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Exosomes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Services), By Workflow (Isolation Methods, Downstream Analysis), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1611070
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 140 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,443,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,862,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,700,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿¢¼ÒÁ» ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ¿¢¼ÒÁ» ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 7¾ï 9,420¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 2025-2030³â µ¿¾È 28.73%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¿¢¼ÒÁ» ºÐ¸® ¹× ºÐ¼® ÀýÂ÷ÀÇ ±â¼ú ¹ßÀü, ¿¢¼ÒÁ» ¿¬±¸¸¦ À§ÇÑ Á¤ºÎ ¹× ºñÁ¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ ¼ºÀå, ¾Ï À¯º´·ü Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2020³â ¾ÏÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â ¾à 1,000¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¾ÏÀº Àü ¼¼°è ÁÖ¿ä »ç¸Á ¿øÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ »ê¾÷Àº ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ½Äº°, °¨¿° ÀÎÀÚ Å½Áö, ½Å°æ ÅðÇ༺ ¹× ½ÉÇ÷°üÁúȯ(CVDs)ÀÇ Ä¡·á ¿É¼Ç ¹ß°ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ±Þ¼ÓÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¼¼Æ÷¿¡¼­ ü¾×À¸·Î ¹æÃâµÇ´Â ¿¢¼ÒÁ»Àº °Ç°­ÇÑ »ç¶÷¿¡ ºñÇØ ´Ù¾çÇÑ Áúº´À» ¾Î°í Àִ ȯÀÚ¿¡¼­ ´Ù¸¥ RNA, ´Ü¹éÁú, ÁöÁú ÇÔ·®À» ³ªÅ¸³À´Ï´Ù. µû¶ó¼­ ¿¢¼ÒÁ»Àº ¹ÙÀÌ¿À¸¶Ä¿ ½Äº°À» ÀÌ¿ëÇÑ Áø´Ü ÀýÂ÷ °³¹ß¿¡ »ç¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ½Å¼ÓÇϰí Á¤È®Çϸç ħ½ÀÀûÀÌÁö ¾ÊÀº Áø´Ü ÀýÂ÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿¢¼ÒÁ» ÀÀ¿ëÀÇ ¼ºÀå ±âȸ·Î À¯¸ÁÇϸç, COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ 2020³â¿¡´Â ¿¢¼ÒÁ»ÀÇ Áø´Ü ¹× Ä¡·á °¡´É¼ºÀ» Á¶»çÇÏ´Â ÀÓ»ó½ÃÇèÀÌ ÁߴܵǾú½À´Ï´Ù. ¶ÇÇÑ, Àü±¹ÀûÀÎ ºÀ¼â ±ÔÁ¦, °ø±Þ¸Á È¥¶õ, COVID-19 °ü·Ã Á¦Ç°¿¡ ´ëÇÑ ÅõÀÚ ÀüȯÀ¸·Î ÀÎÇØ ¿¢¼ÒÁ» °ü·Ã ¿¬±¸ °³¹ß Ȱµ¿ÀÌ °¨¼ÒÇß½À´Ï´Ù.

2020³âÀÇ ¾Ç¿µÇâ¿¡µµ ºÒ±¸Çϰí, À̹ø ÆÒµ¥¹ÍÀº ¿¢¼ÒÁ»À» ÀÌ¿ëÇÑ COVID-19 ¹é½Å ¹× Ä¡·áÁ¦ °³¹ß¿¡ »õ·Î¿î Àü¸ÁÀ» ¿­¾î ÇâÈÄ ¸î ³â µ¿¾È »ê¾÷ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 3¿ù ¹Ì±¹ ¼ÒÀç »ý¸í°øÇÐ ¿¬±¸ ±â°üÀÎ Cell Guidance Systems´Â COVID-19 Áúº´À» Ä¡·áÇϱâ À§ÇÑ ¿¢¼ÒÁ» Ä¡·áÁ¦ °³¹ß °èȹÀ» ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ, ¿¢¼ÒÁ» ¿¬±¸¸¦ À§ÇÑ Á¤ºÎ ¹× ºñÁ¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ ¼ºÀåÀº Á¶»ç ±â°£ µ¿¾È ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 1¿ù ¸¸Æ®¶ó ¹ÙÀÌ¿À(Mantra Bio)´Â ¼±µµÀûÀΠǥÀûÀ» °¡Áø ¿¢¼ÒÁ» Ä¡·á ÇÁ·Î±×·¥ °³¹ßÀ» ÁøÇàÇϱâ À§ÇØ 9¹é¸¸ ´Þ·¯ÀÇ ÀÚ±ÝÀ» Á¶´ÞÇß½À´Ï´Ù.

¶ÇÇÑ 2021³â 2¿ù, Evox Therapeutics´Â ¿¢¼ÒÁ» Ä¡·á¸¦ ¹ßÀü½Ã۰í ÀÚ»çÀÇ ÁÖ¿ä ¿¢¼ÒÁ» Ç÷§Æû DeliverEX¸¦ Àü ¼¼°èÀûÀ¸·Î È®ÀåÇϱâ À§ÇØ 9,518¸¸ ´Þ·¯ÀÇ ÀÚ±ÝÀ» Á¶´ÞÇß½À´Ï´Ù. ±×·¯³ª ¿¢¼Ø Á¦Ç°ÀÇ ½ÂÀÎ ¹× »ó¾÷È­¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦´Â ¿¹Ãø ±â°£ µ¿¾È »ê¾÷ ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¢¼ÒÁ»À» ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡ µµÀÔÇÏ´Â µ¥ µû¸£´Â ±â¼úÀû ¾î·Á¿òÀº ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä °úÁ¦¿¡´Â È¿À²ÀûÀÎ Æ®·£½ºÆå¼Ç Àü·«ÀÇ ºÎÀç¿Í Á¤Á¦ ¹æ¹ýÀÇ ÃÖÀûÈ­ Çʿ伺ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¹®Á¦µéÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¢¼ÒÁ» ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿¢¼ÒÁ» ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¿¢¼ÒÁ» ½ÃÀå : Á¦Ç°°ú ¼­ºñ½ºº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¿¢¼ÒÁ» ½ÃÀå : ¿öÅ©Ç÷ο캰, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¿¢¼ÒÁ» ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¿¢¼ÒÁ» ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå ¿¢¼ÒÁ» ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Exosomes Market Growth & Trends:

The global exosomes market size is estimated to reach USD 794.2 million by 2030, registering to grow at a CAGR of 28.73% from 2025 to 2030 according to a new report by Grand View Research, Inc. The major factors driving the market include technological advancements in exosome isolation and analytical procedures, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer. For instance, according to the World Health Organization (WHO), in 2020 there were about 10 million deaths due to cancer, making it one of the foremost causes of death worldwide. The industry is anticipated to witness rapid growth, owing to the factors, such as the growing need for the identification of cancer biomarkers, detection of infectious agents, and discovery of treatment options for neurodegenerative & Cardiovascular Diseases (CVDs).

Exosomes released by cells into body fluids display different RNA, protein, and lipid contents in patients with various disease conditions as compared to healthy individuals. Hence, exosomes can be used for the development of diagnostic procedures using biomarker identification. The rising demand for fast, accurate, and minimally invasive diagnostic procedures, thus, represents a promising opportunity for the growth of exosome applications. The COVID-19 pandemic led to the disruption of clinical trials investigating the diagnostic and therapeutic potential of exosomes in 2020. In addition, nationwide lockdown restrictions, disruption of supply chains, and diversion of investments toward COVID-19-related products led to a decrease in the research and development activities involving exosomes.

Despite the adverse impact in 2020, the pandemic has opened up several new prospects for the development of COVID-19 vaccines and treatments with the use of exosomes, which, in turn, is expected to boost industry growth over the coming years. For instance, in March 2021, Cell Guidance Systems, a U.S.-based biotechnology research organization, announced plans for the development of exosome therapeutics for treating COVID-19 disease. Moreover, growth in government and non-government initiatives for exosome research is likely to drive the growth during the study period. For instance, in Jan 2023, Mantra Bio raised funding of USD 9 million to advance the development of its lead-targeted exosome therapeutics program.

Similarly, in February 2021, Evox Therapeutics raised a funding of USD 95.18 million to advance the exosome therapeutics and expand the company's leading exome platform DeliverEX globally. However, stringent regulations pertaining to the approval and commercialization of exosome products may hamper the growth of the industry over the forecast period. In addition, technical difficulties associated with the implementation of exosomes in various applications may hamper the growth during the study period. Some of the major challenges include the lack of efficient transfection strategies and the need for optimization of purification methods. Such, challenges are anticipated to impede the market growth.

Exosomes Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Exosomes Market Variables, Trends & Scope

Chapter 4. Exosomes Market: Product & Service Estimates & Trend Analysis

Chapter 5. Exosomes Market: Workflow Estimates & Trend Analysis

Chapter 6. Exosomes Market: Application Estimates & Trend Analysis

Chapter 7. Exosomes Market: End Use Estimates & Trend Analysis

Chapter 8. Exosomes Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â